Curcumin potentiates the anticancer activity of gefitinib both in vitro and in vivo through the inhibition of EGFR phosphorylation and induces EGFR ubiquitination in non-small cell lung cancer [55]. Here, EGFR is linked to non-small cell lung carcinoma.